#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15650	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2556	753.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1873	1873	T	982	T,G,C	979,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15650	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2556	753.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1607	1607	C	1007	C,T,A	1005,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27116	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4223	801.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1913	1913	A	1110	A,T	1109,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27116	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4223	801.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2547	2547	C	944	C,G	943,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27116	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4223	801.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2621	2621	A	920	A,C	918,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27116	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4223	801.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3173	3173	C	907	C,T	906,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27116	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4223	801.6	0	HET	.	.	.	T1325C,G	.	1325	1325	T	1901	1901	T	1110	T,C,G	861,247,2	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	27	2362	folP	852	852	99.88	folP.l15.c4.ctg.1	2066	142.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5502	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3785	180.9	1	SNP	p	S91F	0	.	.	271	273	TCC	706	708	TCC	204;204;206	T,A;C;C	203,1;204;206	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5502	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3785	180.9	1	SNP	p	D95N	0	.	.	283	285	GAC	718	720	GAC	209;210;210	G;A;C	209;210;210	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5502	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3785	180.9	1	SNP	p	D95G	0	.	.	283	285	GAC	718	720	GAC	209;210;210	G;A;C	209;210;210	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1890	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	2074	113.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	757	759	ACC	201;203;203	A;C;C	201;203;203	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1890	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	2074	113.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	955	957	CAC	222;218;218	C;A;C	222;218;218	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1890	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	2074	113.9	0	.	p	.	0	E117K	NONSYN	349	351	GAA	991	993	AAA	218;222;221	A;A,C;A	218;221,1;221	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1890	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	2074	113.9	1	SNP	p	G45D	0	.	.	133	135	GGC	775	777	GGC	212;213;213	G,A;G;C	211,1;213;213	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1176	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	1468	99.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4924	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3527	174.3	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1925	1927	GCA	236;233;234	G;C;A	236;233;234	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4924	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3527	174.3	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2408	2410	ATT	230;231;231	A;T,C;T	230;230,1;231	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4924	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3527	174.3	1	SNP	p	D86N	0	.	.	256	258	GAC	878	880	GAC	213;215;213	G;A;C	213;215;213	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4924	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3527	174.3	1	SNP	p	S87R	0	.	.	259	261	AGT	881	883	AGT	214;212;206	A;G;T	214;212;206	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4924	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3527	174.3	1	SNP	p	S87W	0	.	.	259	261	AGT	881	883	AGT	214;212;206	A;G;T	214;212;206	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4924	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3527	174.3	1	SNP	p	S87I	0	.	.	259	261	AGT	881	883	AGT	214;212;206	A;G;T	214;212;206	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4924	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3527	174.3	1	SNP	p	S88P	0	.	.	262	264	TCC	884	886	TCC	204;205;207	T;C;C	204;205;207	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4430	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3302	167.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1929	1931	GGC	242;241;236	G;G;C	242;241;236	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4374	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2839	192.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1475	1477	GCA	237;238;237	G;C;A	237;238;237	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4374	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2839	192.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1478	1480	ATC	238;236;228	A;T;C,G	238;236;227,1	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4374	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2839	192.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1490	1492	GTG	225;225;227	G,T;T;G	223,2;225;227	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4374	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2839	192.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1490	1492	GTG	225;225;227	G,T;T;G	223,2;225;227	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4374	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2839	192.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1994	1996	ACC	260;261;261	A;C;C	260;261;261	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4374	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2839	192.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2048	2050	GCG	240;242;240	G;C;G	240;242;240	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4374	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2839	192.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2048	2050	GCG	240;242;240	G;C;G	240;242;240	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4374	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2839	192.2	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2171	2173	GGT	257;257;259	G;G;T	257;257;259	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4374	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2839	192.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2180	2182	GGC	268;266;272	G;G,C;C	268;265,1;272	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4374	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2839	192.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2198	2200	CCG	279;280;279	C;C,T;G	279;279,1;279	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5828	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3622	200.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1857	1859	CTG	236;236;235	C;T;G	235;235;235	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2608	porA	1146	1146	99.65	porA.l15.c30.ctg.1	2436	133.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	857	857	C	208	C	208	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	297	90.03	porB1a.l15.c30.ctg.1	1006	29.2	0	.	p	.	0	H217N	NONSYN	649	651	CAT	731	733	AAT	2;2;2	A;A;T	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	297	90.03	porB1a.l15.c30.ctg.1	1006	29.2	0	.	p	.	0	D218N	NONSYN	652	654	GAT	734	736	AAT	2;2;1	A;A;T	2;2;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	297	90.03	porB1a.l15.c30.ctg.1	1006	29.2	0	.	p	.	0	A222V	NONSYN	664	666	GCT	746	748	GTT	2;2;2	G;T;T	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	297	90.03	porB1a.l15.c30.ctg.1	1006	29.2	0	.	p	.	0	V226A	NONSYN	676	678	GTA	758	760	GCG	2;2;2	G;C;G	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	297	90.03	porB1a.l15.c30.ctg.1	1006	29.2	0	.	p	.	0	.	MULTIPLE	700	702	ACT	781	783	GTA	3;3;3	G;T;A	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	297	90.03	porB1a.l15.c30.ctg.1	1006	29.2	0	.	p	.	0	N237K	NONSYN	709	711	AAC	790	792	AAA	3;3;3	A;A;A	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	297	90.03	porB1a.l15.c30.ctg.1	1006	29.2	0	.	p	.	0	D238fs	FSHIFT	712	712	G	793	793	G	3	G	3	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3112	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1894	201.4	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	967	969	CAA	265;264;262	C,G,A;A;A,C	263,1,1;264;261,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3112	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1894	201.4	0	.	p	.	0	E212G	NONSYN	634	636	GAA	1174	1176	GGT	270;272;273	G,C;G;T	269,1;272;273	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3112	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1894	201.4	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1177	1179	GAT	272;266;266	G,C;A;T	270,1;266;266	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3112	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1894	201.4	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1183	1185	GCT	269;262;264	G;C;T	269;262;264	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3112	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1894	201.4	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1192	1194	ATG	256;255;253	A,T,G,C;T;G	252,2,1,1;255;253	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3112	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1894	201.4	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1309	1311	AAG	265;265;267	A;A;G	265;265;267	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3112	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1894	201.4	1	SNP	p	G120K	0	.	.	358	360	GGC	898	900	GGC	257;260;259	G;G;C	257;260;259	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11336	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5414	261.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2220	2222	CAT	312;308;310	C,T;A;T,A	311,1;308;309,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1736	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1579	137.2	1	SNP	p	V57M	0	.	.	169	171	GTG	793	795	GTG	294;294;295	G,A;T,G;G,A	293,1;293,1;294,1	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
